Supplementary Figure 7 from <i>p53-Inducible Ribonucleotide Reductase</i> (<i>p53R2/RRM2B</i>) Is a DNA Hypomethylation–Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia

Petra A. Link,Maria R. Baer,Smitha R. James,David A. Jones,Adam R. Karpf

crossref（2023）

引用 0|浏览10

暂无评分

摘要

Supplementary Figure 7 from p53-Inducible Ribonucleotide Reductase (p53R2/RRM2B) Is a DNA Hypomethylation–Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 7 from &lt;i&gt;p53-Inducible Ribonucleotide Reductase&lt;/i&gt; (&lt;i&gt;p53R2/RRM2B&lt;/i&gt;) Is a DNA Hypomethylation–Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia

Supplementary Figure 7 from <i>p53-Inducible Ribonucleotide Reductase</i> (<i>p53R2/RRM2B</i>) Is a DNA Hypomethylation–Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia